Related Experiment Videos

[Beta-blockers in the treatment of chronic heart failure]

M Knazeje1, M Belicová, J Kerný

  • 1I. interná klinika MFN, Martin, Slovenská republika.

Vnitrni Lekarstvi
|June 14, 2002
PubMed

Insights

Beta-blockers offer therapeutic benefits for cardiac failure by modulating the sympathetic nervous system. This review summarizes key clinical studies and practical principles for their effective use in heart failure management.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Cardiac failure presents significant medical and societal challenges, necessitating effective prevention and treatment strategies.
  • The sympathetic nervous system plays a crucial role in the pathogenesis of cardiac failure.

Purpose:

  • To review the therapeutic use of beta-blockers in treating cardiac failure.
  • To analyze the role of the sympathetic nervous system in cardiac failure and the rationale for beta-blocker therapy.

Summary:

  • The review covers major clinical studies, both completed and ongoing, concerning beta-blocker treatment for cardiac failure.
  • It discusses the theoretical basis for using beta-blockers, focusing on their impact on the sympathetic nervous system.
  • Practical guidelines for employing beta-blockers in cardiac failure are outlined.

Impact:

  • Provides a comprehensive overview of beta-blocker therapy for cardiac failure.
  • Informs clinical practice with evidence-based principles for managing heart failure.
  • Highlights the importance of understanding the sympathetic nervous system in cardiac failure treatment.

Related Concept Videos